Increased amounts of C3a and the terminal complement complex at high dialysis blood-flow: The relation with dialysis efficiency

Nephron

Volumn 72, Issue 4, 1996, Pages 523-529

  Skroeder, Richard ^a   Kjellstrand, Per ^b   Holmquist, Björn ^c   Nilsson, Ulf ^d   Jacobson, Stefan H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Gambro AB   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

Biocompatibility; C3a; Dialysis efficiency; Hemodialysis; Net generation of complement; Net generation of terminal complement complex; Terminal complement complex

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ADULT; AGED; ARTICLE; BIOCOMPATIBILITY; BLOOD FLOW; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; FEMALE; HEMODIALYSIS; HUMAN; IMMUNE RESPONSE; LEUKOCYTE COUNT; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

COMPLEMENT C3A; COMPLEMENT MEMBRANE ATTACK COMPLEX; FEMALE; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RENAL CIRCULATION; RENAL DIALYSIS;

EID: 0030009623     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188933     Document Type: Article

References (35)

1. Held J. Levin N. Bovbjerg R. Pauly M, Dia-mon L: Mortality and duration of hemodialysis treatment. J Am Med Assoc 1991;7:871-875.
2. US Renal Data System: USRDS 1989 Annual Data Report. Bethesda. Md. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1989.
3. Skroeder R. Jacobson SH. Kjellstrand P. Bo-berg U, Kjellstrand C: K and T covariate with V in hemodialysis: As K increases and T decreases. V also decreases. Trans ASAIO 1991: 37:129-132.
4. Mahioul A. Meinhold H. Kessel M. Schulze H. Baurmeister U: Dialyzer membranes: Effects of surface area and chemical modification of cellulose on complement and platelet activation. Artif Organs 1987; 11:149-154.
5. Craddock P. Fehr J. Dalmasso A. Brigham K. Jacob H: Hemodialysis leukopenia: Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977:59:879-888.
6. Skroeder R. Jacobson SH. Lins L-E. Kjellstrand C: Acute symptoms during and between hemodialysis: The relative role of speed, duration and biocompatibilitv of dialysis. Artif Organs 1994;18:880-887.
7. Bergamo Collaborative Dialysis Study Group: Acute intradialytic well-being: Results of a clinical trial comparing polysulphonc with cupro-phan. Kidney Int 1991;40:714-719.
8. lnvanovich P. Chenowcth D. Schmidt R, Klinkmann H, Boxer L. Jacob H. Hammer-schmidt D: Symptoms and activation of granulocytes and complement with two dialysis membranes. Kidney Int 1983:24:758-763.
9. Hakim R. Breillat J. Lazarus J, Pork R: Complement activation and hypersensitivity reaction to dialysis membranes. N Engl J Med 1984:311:878-882.
10. Johnson R.I: Complement activation during extracorporeal therapy: Biochemistry, cell biology and clinical relevance. Nephrol Dial Transplant 1994;9(suppl):23-45.
11. Deppisch R, Schmitt V. Bommer J. Hansch G. Ritz E, Rauterberg E: Fluid phase generation of terminal complement complex as a novel index of biocompatibilitv. Kidney Int 1990:37:696-706.
12. Podack E: Assembly and functions of the terminal components, in Ross G (ed): Immunobiology of the Complement System. Orlando. Academic Press. 1986, pp 115-136.
13. Pekna VI. Larsson R. Formgren B. Nilsson UR. Nilsson B: Complement activation by polymethyl methacrylate minimized by end-point heparin attachment. Biomaterials 1993:14:189-192.
14. Basile C. Casino F. Lopez T: Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way. Am J Kidney Dis 1990:15:40-45.
15. Kishimoto T. Kyo M, Yamagami S. Maekawa M: Effect of membrane area and blood flow rate on plasma C3a and C5a concentrations during hemodialysis with regenerated cellulos-ic membrane dialyzers. Nephrol Dial Transplant 1989;4:46-49.
16. Jorstad S. Smebv LC. Balstad T. Widcrae T-E: Generation and removal of anaphvlatoxins during hemofiltration with five different membranes. Blood Purif 1988:6:325-335.
17. Cheung AK: Interactions between plasma proteins and hemodialysis membranes: in Griin-feld J. Beck J, Kreis H. Maxwell M (eds): Advances in Nephrology, ed 22. Boston. Mos-by Year Book. 1993. pp 417-434.
18. Chcnoweth D: Complement activation during hemodialysis: Clinical observations, proposed mechanisms and theoretical implications. Artif Organs 1984:8:281-290.
19. Law SK. Levine RP: Interaction between the third complement protein and cell surface macromolecules. Proc Natl Acad Sci USA 1977:74: 2701-2705.
20. Law SK. Lichtenberg NA, Levine RP: Covalent binding and hemolytic activity of complement proteins: Inactivation by amines. Proc Natl Acad Sci USA 1980:77:7194-7198.
21. Cheung AK. Parker CJ. Wilcox LA, Janatova J: Activation of complement by hemodialysis membranes: Polyacrylonitrile binds more C3a than cuprophan. Kidnev Int 1990:37:1055-1059.
22. Springer TA: Adhesion receptors of the immune system. Nature 1990:346:425-434.
23. Amaout M A: Structure and function of the leukocyte adhesion molecules CD 11/CD 18. Blood 1990;75:1037-1050.
24. Podack ER. Müller-Eberhard HJ: Isolation of human S-protein. an inhibitor of membrane attack complex of complement. J Biol Client 1979, 254:9908-9914.
25. Ohi H. Sakamoto K. Hatano M: S-protein (vitronectin) in hemodialysis patients. Nephron 1990;54:190-191.
26. Deppisch R. Ritz E. Hansch GM. Schöls M, Rauterberg E-W: Bioincompatibility: Perspectives in 1993. Kidney Int 1994:45:S77-S84.
27. Lundahl J. Hed J. Jacobson SH: Dialysis granulocytopenia is preceded by an increased surface expression on the adhesion-promoting glu-coprotein Mac-1. Nephron 1992:61:163-169.
28. Thylén P. Lundahl J. Fcmvik E. Hed J. Svcn-son SB. Jacobson SH: Mobilization of an intracellular glycoprotein (Mac-1) on monocytes and granulocytes during hemodialysis. Am J Nephrol 1992;12:393-400.
29. Himmelfarb J, Zaoui P. Hakim R. Holbrook D: Modulation of granulocyte LAM-1 and MAC-1 during dialysis: A prospective, randomized controlled trial. Kidney Int 1992:41: 388-395.
30. Kessler M. Hoen B, Mayeux D, Hestin D. Fon-tcnaille C: Bacteremia in patients on chronic hemodialysis. Nephron 1993:64:95-100.
31. Vanholdcr R. Ringoir S. Dhondt A. Hakim R: Phagocytosis in uremic and hemodialysis patients: A prospective and cross-sectional study. Kidney Int 1991:39:320-327.
32. Frostcgàrd J. Nilsson J. Haegerstrand A. Hamstcn A, Wigzell H, Gidlund M: Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U 937. Proc Natl Acad Sci USA 1990:87:904-908.
33. Hakim RM: Clinical implications of hemodialysis membrane biocompatibilitv (editorial review). Kidney Int 1993;44:484-494.
34. Gutierrez A, Alvestrand A, Wahren J. Bergstrom J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 1990:38:487-494.
35. C'harra B, Calemard E. Ruffel M. Chazot C. Terrât J-C, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 1992: 41:1286-1291.